Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance

Michelle Doyle, Lenka A. Vodstrcil, Erica L. Plummer, Ivette Aguirre, Christopher K. Fairley, Catriona S. Bradshaw

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)


In the era of increasing macrolide- and quinolone-resistant Mycoplasma genitalium (MG), we report the efficacy of 2 nonquinolone antimicrobials in patients with limited treatment options. Pristinamycin + doxycycline cured 75% (95% CI, 64%-85%), and minocycline cured 71% (95% CI, 54%-85%) of cases. These data provide useful estimates to inform clinical practice.

Original languageEnglish
Article numberofaa291
Number of pages4
JournalOpen Forum Infectious Diseases
Issue number8
Publication statusPublished - Aug 2020


  • Multidrug failure
  • Mycoplasma genitalium
  • Sexually transmitted infections
  • Treatment

Cite this